- Heart valve repair and replacement, encompassing surgical and transcatheter interventions, are increasingly vital components of modern cardiovascular care in both hospital and ambulatory settings due to their life-saving role, technological advancements, and growing clinical acceptance of minimally invasive procedures
- The escalating demand for heart valve therapies is primarily fueled by the rising prevalence of valvular heart diseases, aging populations, and increasing awareness about early diagnosis and timely intervention
- North America dominated the heart valve repair and replacement market with the largest revenue share of 39.2% in 2024, characterized by advanced healthcare infrastructure, high procedure volumes, favorable reimbursement policies, and the presence of key industry players, with the U.S. experiencing significant procedural growth driven by innovations in transcatheter aortic valve replacement (TAVR) and mitral repair technologies
- Asia-Pacific is expected to be the fastest growing region in the heart valve repair and replacement market during the forecast period due to increasing healthcare access, medical tourism, and improving diagnostic capabilities
- TAVI/TAVR Valves segment dominated the heart valve repair and replacement market with a market share of 44.1% in 2024, driven by its minimally invasive nature, shorter recovery times, and increasing adoption among high-risk and elderly patients unsuitable for open-heart surgery
